Health care has emerged as a key issue in both congressional and state elections this year.
To bottle up the movement to tax sugary drinks, major beverage companies like Coca-Cola and PepsiCo are spending millions of dollars on commercials that push people to vote to prohibit local governments from slapping levies on certain foods and drinks, The New York Times reported on Saturday.
Every year, health officials warn people to get their flu shots. Every year, people ignore those calls.
Esperion’s experimental treatment for lowering cholesterol is poised to help millions of patients, CEO Tim Mayleben told CNBC on Wednesday.
The Food and Drug Administration has had “constructive” meetings with e-cigarette manufacturers since instructing them to fix “epidemic” levels of teen nicotine use, Commissioner Scott Gottlieb said Wednesday.
Last quarter, Pfizer Chief Ian Read was upbeat on the Trump administration’s plan to lower drug prices, even after a Trump tweet that led to his company deferring planned price increases.
Goop, the lifestyle brand owned by actress Gwyneth Paltrow, has been reported to the U.K.’s trading standards and advertising watchdogs over allegations that it makes misleading claims about its products.
The Trump administration is battling rising health costs by going after the incentives that help drive higher prices.
Gary Gottlieb is in a prime spot to see how technology companies are shaking up health care.
Health and Human Services Secretary Alex Azar had a stern warning for the pharmaceutical industry on Friday, a day after the Trump administration proposed a plan to change the way Medicare pays for certain expensive drugs.
President Donald Trump said Medicare will start negotiating drug prices to bring costs in line for its Part B coverage with what other nations pay for the same drugs.
The booming U.S. economy appears to be reducing dependence on federal health insurance for the poor.
Tesla CEO Elon Musk briefly moved away from talking about cars during Wednesday’s earnings call to rave about his company’s new health clinics for employees.
Udi Manber, who ran engineering for Google’s core search products and previously held senior roles at Yahoo and Amazon, is joining health insurance giant Anthem as the head of artificial intelligence, according to people familiar with the matter.
Biotech giant Amgen is lowering the price of its cholesterol medicine Repatha by almost 60 percent, following a similar move from its competitor, after both drugs failed to meet sales expectations. The new price of the medicine will be $5,850 per year, Amgen said in a statement Wednesday. That’s down from an annual price of
The Food and Drug Administration has approved Xofluza, the first new antiviral flu treatment in nearly 20 years.
Tracy Pugh, an event planner based in Oakland, Calif., had a hard time breastfeeding her second child. So, when her third baby was just a few weeks old, she decided to invest about $1,000 into a “smart” breast pump from a Silicon Valley-backed start-up called Naya Health.
Don’t look now, but America’s first Trump-era midterm election could substantially expand Obamacare.
Leading e-cigarette manufacturer Juul spent half a million dollars on lobbying last quarter — up 167 percent from the previous quarter — as regulators weigh restrictions on the industry to stem a surge in teens using the devices.
Uncle Sam has a birthday gift for certain people who make it to 100: A tax bill.
When pharma giant Pfizer announced in January it planned to shut down early- and mid-stage neuroscience drug development, it was another blow to a field already in a defensive crouch.